NEA Management Company, LLC Q2 2016 Filing

Filed August 5, 2016

Portfolio Value

$1.9T

Holdings

39

Report Date

Q2 2016

Filing Type

13F-HR

All Holdings (39 positions)

#StockSharesValue% PortfolioType
1
TESARO INC
10,275,113$863.6B44.82%
2
GRPNCHFGROUPON INC
33,109,905$107.6B5.59%
3
SENS1GBPSENSEONICS HOLDINGS INC
26,303,189$103.4B5.37%
4
ARDXARDELYX INC
11,792,631$103.0B5.34%
5
DERMIRA INC
3,506,649$102.6B5.32%
6
ADAPYADAPTIMMUNE THERAPEUTICS
9,880,999$80.5B4.18%
7
EPIZYME INC
6,260,851$64.1B3.33%
8
GLYCEURGLYCOMIMETICS INC
8,584,128$62.4B3.24%
9
NVROEURNEVRO CORP
660,428$48.7B2.53%
10
LOXO ONCOLOGY INC
1,792,207$41.5B2.16%
11
CARE COM INC
3,260,989$38.1B1.98%
12
PROTEOSTASIS THERAPEUTICS INC
3,095,240$37.5B1.95%
13
LXRXLEXICON PHARMACEUTICALS INC
2,382,286$34.2B1.77%
14
ENDOLOGIX INC
2,490,204$31.0B1.61%
15
AEROHIVE NETWORKS INC
4,681,455$31.0B1.61%
16
TREVENA INC
3,811,691$24.0B1.25%
17
ACHAOGEN INC
4,715,128$17.9B0.93%
18
EX9EXELIXIS INC
2,207,000$17.2B0.89%
19
CLVSEURCLOVIS ONCOLOGY INC
1,139,890$15.6B0.81%
20
MIRNA THERAPEUTICS INC
2,974,811$12.7B0.66%
21
CASCADIAN THERAPEUTICS INC
10,750,000$10.1B0.52%
22
AVEO PHARMACEUTICALS INC
10,362,694$9.9B0.52%
23
STRONGBRIDGE BIOPHARMA PLC
2,141,308$8.5B0.44%
24
TRACON PHARMACEUTICALS INC
1,889,652$8.3B0.43%
25
RIGLUSDRIGEL PHARMACEUTICALS INC
3,243,150$7.2B0.38%
26
AUPHAURINIA PHARMACEUTICALS INC
2,546,843$7.1B0.37%
27
AKARI THERAPEUTICS PLC
452,167$6.1B0.32%
28
ZHONE TECHNOLOGIES INC
4,781,290$5.7B0.30%
29
ARQULE INC
2,520,316$4.8B0.25%
30
SUNESIS PHARMACEUTICALS INC
7,789,644$4.3B0.22%
31
ARCA BIOPHARMA INC
1,460,209$4.2B0.22%
32
CSBRCHAMPIONS ONCOLOGY INC
1,562,500$3.4B0.17%
33
ZOSANO PHARMA CORP
2,158,543$2.7B0.14%
34
ROKA BIOSCIENCE INC
3,220,433$1.8B0.10%
35
OREXIGEN THERAPEUTICS INC
370,900$1.6B0.08%
36
CERECOR INC
595,435$1.3B0.07%
37
AGILE THERAPEUTICS PLC
133,488$1.0B0.05%
38
CATALYST BIOSCIENCES INC
652,380$992.0M0.05%
39
PARATEK PHARMACEUTICALS INC
66,245$921.0M0.05%